Compare Becton Dickinson and Co (BDX) vs Plug Power Inc (PLUG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Becton Dickinson and Co vs Plug Power Inc — how do they compare? Becton Dickinson and Co trades at $156.36 (market cap $41.51B), while Plug Power Inc trades at $2.18 (market cap $3.17B). The key difference: Becton Dickinson and Co is far larger — about 13.1× Plug Power Inc's market cap, and Becton Dickinson and Co pays a 2.79% dividend while Plug Power Inc pays none. Which is the better fit depends on your goals.
| BDX | PLUG | |
|---|---|---|
Market Cap | $41.51B | $3.17B |
Sector | Health | Industrials |
52-Week High | $185.39 | $4.14 |
52-Week Low | $135.49 | $1.40 |
Enterprise Value | $57.97B | $3.95B |
Dividend Yield | 2.79% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BDX trades at $153.83, up 1.24% today, with technical indicators showing a neutral to bullish bias. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $2.90 exceeding expectations. Revenue growth remains steady, reaching $21.84B in 2025, though net margins have compressed to 5.12%. Recent news highlights BDX's innovation in medical technology and positive analyst sentiment.
The outlook for BDX appears balanced. Upside potential exists from continued earnings beats and strategic positioning in growing healthcare segments like GLP-1 drug support equipment. However, risks include margin pressure, elevated debt levels, and cautious hospital spending. The consensus price target of $173.40 suggests moderate upside from current levels.
Plug Power (PLUG) trades at $2.17, down 2.69% with a bearish technical signal. The company shows persistent financial challenges with negative profit margins (-227.13% net income margin) and cash flow issues, though recent asset sales aim to improve liquidity. Revenue grew to $710M in 2025 but remains unprofitable with significant losses. Analyst sentiment is mixed with 44.7% buy ratings and a $2.92 consensus target, while technical indicators show oversold conditions with RSI at 18.61.
The outlook remains challenging with profitability projected for 2028, but execution risks and continued cash burn pose significant hurdles. Near-term catalysts include $80M liquidity from recent asset sales and project milestones, though elevated short interest at 27.4% reflects skepticism. Investors face high volatility amid the company's turnaround efforts in the competitive hydrogen sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Becton Dickinson and Co
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Interventional (largely the former Bard business) accounts for 23% of revenue. International revenue accounts for 44% of the company's business.
Read more on BDX →About Plug Power Inc
Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.
Read more on PLUG →
